Skip to content
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
Search
Search
Close
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
×
Home
About MedNet
Live Programs
Webcasts
Contact
Log in/Registration
0
0
Sub-Total:
$
0.00
No products in the cart.
100% Secure Checkout!
Home
/
Specialty
/
Cardiology
/ Efficacy and Safety of Fixed-ratio Combination of Insulin Degludec and Liraglutide (IDegLira) and Insulin Glargine and Lixisenatide (IGlarLixi) in Patients with Type 2 Diabetes
Efficacy and Safety of Fixed-ratio Combination of Insulin Degludec and Liraglutide (IDegLira) and Insulin Glargine and Lixisenatide (IGlarLixi) in Patients with Type 2 Diabetes
Complimentary
Categories:
Activity Type
,
ANCC
,
Cardiology
,
CME
,
Credit Type
,
Endocrinology
,
Family Medicine
,
Nurse
,
Nurse Practitioner
,
Online Activity
,
Physician
,
Physician Assistant
,
Profession
Related products
Sustained-Release Drug Delivery System in the Management of Glaucoma
Read more
Cataracts: Advances in Imaging, Intraocular Lenses, and Surgical Procedures
Read more
Novel Therapies for Chronic Rhinosinusitis with Nasal Polyps
Read more
Emerging Treatment Options for Pustular Psoriasis
Read more
Scroll To Top